trending Market Intelligence /marketintelligence/en/news-insights/trending/J6GfKlSaxWFw76Kyz4N6mw2 content esgSubNav
In This List

Zosano Pharma independent director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Zosano Pharma independent director resigns

Bruce Steel resigned as a class II independent director of Zosano Pharma Corp., effective Dec. 13.

Steel's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices.

Additionally, the board decided to reduce its size to five members, effective upon Steel's resignation.